Screening Modalities for Colon Cancer: What You Need to Know (GI Insights)

In this discussion, Dr. Peter Buch and Dr. Aasma Shaukat explore the evolving landscape of colon cancer screening. While stool-based tests like FIT and multitarget DNA remain standard, screening rates are still low. With the rise of noninvasive blood-based options, accessibility is improving. Dr. Shaukat shares insights on the effectiveness of current and emerging methods, and strategies for boosting screening uptake.